Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Portugal

Gouveia, M; Fiorentino, F; Jesus, G; Costa, J; Borges, M

http://hdl.handle.net/10400.17/3234

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
Ped Infect Dis J 2017_36_782.pdf		172.65 KB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Resumo(s)

Pneumococcal infections are the leading cause of vaccine-preventable death in children. In June 2015, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the Portuguese Immunization Program. We evaluated the cost-effectiveness of children vaccinated with PCV13 versus no vaccination for preventing pneumococcal diseases.

Palavras-chave

Child, Preschool Cost-Benefit Analysis Humans Incidence Infant Immunization Models, Immunological Pneumococcal Infections Pneumococcal Vaccines CHLC FAR

URI

http://hdl.handle.net/10400.17/3234

Citação

Pediatr Infect Dis J. 2017 Aug;36(8):782-787

Editora

Wolters Kluwer

DOI

10.1097/INF.0000000000001587

Coleções

FAR - Artigos

Métricas Alternativas

Ver registo completo